How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.
- DOI
- 10.1136/rmdopen-2020-001363
- Published
- 2020 Sep
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2020-001363,
title = {How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.},
author = {Chatzidionysiou K and Delcoigne B and Frisell T and Hetland ML and Glintborg B and Dreyer L and Cordtz R and Zobbe K and Nordström D and Trokovic N and Aaltonen K and Provan SA and Grondal G and Gudbjornsson B and Askling J},
year = {2020},
journal = {RMD open},
doi = {10.1136/rmdopen-2020-001363},
url = {https://doi.org/10.1136/rmdopen-2020-001363}
}RIS
TY - JOUR TI - How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers. AU - Chatzidionysiou K AU - Delcoigne B AU - Frisell T AU - Hetland ML AU - Glintborg B AU - Dreyer L AU - Cordtz R AU - Zobbe K AU - Nordström D AU - Trokovic N AU - Aaltonen K AU - Provan SA AU - Grondal G AU - Gudbjornsson B AU - Askling J PY - 2020 JO - RMD open DO - 10.1136/rmdopen-2020-001363 UR - https://doi.org/10.1136/rmdopen-2020-001363 ER -
APA
K, C., B, D., T, F., ML, H., B, G., L, D., R, C., K, Z., D, N., N, T., K, A., SA, P., G, G., B, G., & J, A. (2020). How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.. RMD open. https://doi.org/10.1136/rmdopen-2020-001363
Source records
- pubmed · retrieved 2026-09-26T04:23:19.687Z